probiotics

Gut microbiota maturation may be linked to infection risk in preterm babies

Bacteria such as Enterococcus faecium and Limosilactobacillus reuteri are key in activating an immune receptor that boosts the activity of protective immune cells.

Unlocking Healthy Aging: How the Microbiome Shapes Longevity 

A deep dive into how microbiome health influences aging, and why restoring gut balance is emerging as a powerful strategy to support resilience, reduce inflammation, and extend health span.

From tradition to innovation: the new age of fermented cosmetic ingredients

Building the future with advanced biotechnology.

Vitafoods Europe 2026: from market expansion to innovation in action

The report by MicrobiomePost distills key trends from Vitafoods Europe 2026.

Region-specific infant gut bacteria may pave the way for tailored probiotics

Bifidobacterium longum and B. infantis are distinct species with strains adapted to local diets, highlighting the importance of developing geographically tailored infant probiotics.

Targeting the gut microbiota in IBD: from diet and probiotics to fecal microbiota transplantation

Giovanni Marasco, University of Bologna, discusses the growing evidence that links gut microbiota dysbiosis to the pathophysiology, clinical prognosis, disease progression, and treatment response of patients with IBD.

Probiotics in focus: key clinical and translational papers shaping the field

Francisco Guarner Aguilar reviewed some of the most significant probiotic-related papers published in recent years, spanning basic research, clinical trials, and population-based studies.

From dysbiosis to long-term outcomes: Flavia Indrio wraps up PPPP 2026

Prof. Flavia Indrio reflects on the main take-home messages from the congress, which brought together 32 leading international experts in microbiota research, allergy, nutrition, gut-brain axis and lung disease.

Oral microbiota therapy rebuilds gut bacteria to prevent recurrent C. difficile infection

VOS, an FDA-approved oral microbiota therapy, has been shown to reduce infection risk compared to traditional fecal transplants. 

Oral Microbiome: a new window on systemic health—and a clinical opportunity for evidence-based probiotics

Gianfranco Grompone, Chief Scientific Officer at BioGaia GA, discusses the new evidences about oral microbiome.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.